Disruptions in energy metabolism within skeletal cells play a critical role in the pathogenesis of diabetic osteoporosis (DOP), primarily by affecting boneâs metabolic balance. The exact causes and regulatory mechanisms of these energy metabolism disorders in DOP remain unclear. Angiopoietin-like protein 8 (ANGPTL8), a protein involved in energy metabolism, is elevated in diabetics. This study aimed to investigate the role of ANGPTL8 in DOP development. In this study, a murine model of diabetic osteoporosis was developed, and an increase in plasma levels of ANGPTL8 was observed. The knockout of ANGPTL8 in diabetic mice mitigated osteoporosis, as demonstrated by micro-computed tomography (Micro-CT) analysis. Immunohistochemical analysis revealed that ANGPTL8 knockout increased the number of osteoblasts and decreased the number of osteoclasts in the femur. Moreover, in vitro cellular experiments demonstrated that ANGPTL8 inhibited the phosphorylation of AMPK through binding to PirB, resulting in decreased activity of the PFK1 enzyme and increased activity of the PDH enzyme. This metabolic modulation reduced glycolysis and increased oxidative phosphorylation within the cells. The alteration in metabolic pathways induced by ANGPTL8 suppressed the differentiation of osteoblastic precursor cells while facilitating the differentiation of osteoclastic precursor cells. In conclusion, ANGPTL8 alters energy metabolism to inhibit osteoblastic differentiation and promote osteoclastic differentiation by inhibiting the AMPK signaling pathway. This change in energy metabolism subsequently resulting in an imbalance between osteoblasts and osteoclasts, ultimately exacerbating diabetic osteoporosis. These findings provide new insights into DOPâs pathogenesis and suggest ANGPTL8 as a potential therapeutic target for its treatment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00018-025-06077-x.
ANGPTL8 accelerates bone loss in diabetic mice by promoting osteoclastic differentiation and inhibiting osteoblastic differentiation through AMPK pathway-mediated metabolic reprogramming.
ANGPTL8 通过 AMPK 通路介导的代谢重编程,促进破骨细胞分化并抑制成骨细胞分化,从而加速糖尿病小鼠的骨质流失。
阅读:2
作者:
| 期刊: | Cellular and Molecular Life Sciences | 影响因子: | 6.200 |
| 时间: | 2026 | 起止号: | 2026 Feb 23; 83(1):128 |
| doi: | 10.1007/s00018-025-06077-x | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
